Advances in APOL1 Therapeutics

Webinar | APOL1-mediated kidney disease: Overview and Implications for Care | AKFПодробнее

APOL1 & Kidney Disease: Progress Toward Precision Medicine | DoM Grand Rounds | 30 March 2022Подробнее

APOL1 - A Story from Bench to BedsideПодробнее

APOL1 and Chronic Kidney Disease: Advances and ChallengesПодробнее

APOL1-Associated Nephropathy: Pathology, Mechanisms, and Clinical Utility - Dr. Barry FreedmanПодробнее

Emerging Therapeutics for APOL1-Mediated Kidney DiseaseПодробнее

Emerging Research with Global Implications: Identification & Diagnosis of Kidney Diseases - APOL1Подробнее

APOL1 Controversies Conference Plenary Presentation: APOL1 Diagnostics and TherapeuticsПодробнее

Emerging Therapeutics: APOL1-Mediated Kidney DiseaseПодробнее

Brendan Shannon, MD - APOL1 Testing: A Global PerspectiveПодробнее

Adriana Hung, MD, MPH - APOL1 Mediated Kidney Disease: Toward Precision Medicine ApproachesПодробнее

NMQF Webinar: Understanding Genetic Kidney Diseases: Insights into APOL1Подробнее

APOL1 - A Story from Bench to BedsideПодробнее

NephCure U: APOL1Подробнее

Living with APOL1-mediated kidney disease: Dr. Kendra Richardson’s story | Vertex PharmaceuticalsПодробнее

“APOL1 Plus” Genotypes in Patients with Chronic Kidney Disease | ASN AbstractПодробнее

APOL1-mediated kidney disease | Rare Kidney Disease | AKFПодробнее

Effect of a Single APOL1 Gene Nephropathy Variant on the Risk of Advanced LN in BraziliansПодробнее

Vertex Forward: Exploring APOL1-Mediated Kidney Disease (AMKD) | Vertex PharmaceuticalsПодробнее